Carlsmed, Inc. (CARL)
NASDAQ: CARL · Real-Time Price · USD
16.37
+0.08 (0.49%)
Sep 1, 2026, 4:00 PM EDT - Market closed

Carlsmed Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23
447328--
Market Cap Growth
26.42%---
Enterprise Value
380231--
Last Close Price
16.3712.35--

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23
PS Ratio
7.066.50--
PB Ratio
5.293.32--
P/TBV Ratio
5.313.32--

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23
EV/Sales Ratio
6.004.56--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23
Debt / Equity Ratio
0.260.180.67-4.14
Net Debt / Equity Ratio
-0.80-0.93-0.90-1.51
Net Debt / EBITDA Ratio
1.763.050.96-0.23
Net Debt / FCF Ratio
1.953.120.90-0.24
Asset Turnover
0.740.560.83-
Inventory Turnover
8.858.789.07-
Quick Ratio
8.318.485.321.40
Current Ratio
8.848.875.601.58
Return on Equity (ROE)
-66.14%-47.62%-212.36%-
Return on Assets (ROA)
-28.19%-21.00%-45.79%-
Return on Capital Employed (ROCE)
-36.50%-26.40%-56.10%-282.40%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23
Earnings Yield
-8.13%-9.03%--
FCF Yield
-7.74%-9.02%--
Buyback Yield / Dilution
-496.29%-249.74%-4.62%-
SEC Filings: 10-K · 10-Q